Cipla has made a groundbreaking move in India’s healthcare sector with the launch of Methenamine Hippurate, a non-antibiotic drug for patients suffering from recurrent Urinary Tract Infections (UTIs), under the brand name HUENA.
UTIs are a major health concern in India and are the second-most common reason for antibiotic use, with infection rates doubling over the last 30 years. Women are particularly susceptible, accounting for 15% of all antibiotic prescriptions in the country.
💊 What is HUENA?
HUENA offers a non-antibiotic alternative for preventing UTIs by targeting bacteria in the bladder and urinary tract, without contributing to antibiotic resistance.
Key Benefits:
- Effective in preventing recurrent UTIs
- Comparable to long-term, low-dose antibiotic therapy
- Lower treatment costs
- Zero risk of antimicrobial resistance
“The launch of HUENA reflects our strong commitment to antimicrobial stewardship and addressing the growing challenge of Anti-Microbial Resistance (AMR). This innovation will improve patient outcomes while reducing reliance on antibiotics,” said Achin Gupta, Global COO, Cipla.
🌍 Significance in India
Being the first drug of its kind in India, HUENA represents a major advancement in the fight against AMR.
Highlights:
- Provides a safe alternative to long-term antibiotic therapy
- Supports global efforts to combat AMR
- Improves patient adherence due to non-antibiotic formulation
“This groundbreaking launch provides patients with a non-antibiotic drug that will help prevent urinary tract infections without contributing to antimicrobial resistance,” said Jaideep Gogtay, Global CMO, Cipla.
⚕️ Cipla’s Recent Innovations
Cipla has been at the forefront of pharmaceutical innovation in India:
- Approved by CDSCO last year to market inhaled insulin (Afrezza) for diabetes
- Afrezza is a rapid-acting insulin administered via inhalation rather than injection
- Cipla has a presence in 74 global markets, catering to innovative treatments worldwide
📌 Why HUENA Matters
With antibiotic resistance becoming a global health crisis, HUENA offers:
- A preventive solution for millions of Indian patients
- Reduced dependence on traditional antibiotics
- A step forward in antimicrobial stewardship
Patient Tip: If you experience recurrent UTIs, consult a healthcare professional to discuss whether HUENA could be a suitable preventive option for you.
